Skip to content

Fragile promise of psychedelics in psychiatry

Cédric Lemarchand, Raphaël Chopin, M Paul, Alain Braillon, Lisa Cosgrove, Ioana A. Cristea, Eiko I. Fried, Erick H Turner, Florian Naudet

BMJ November 19, 2024 DOI: 10.1136/bmj-2024-080391 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Keywords Data science World wide web
Citations 9
Key findings The evidence on hallucinogen efficacy and safety has weaknesses, and the use of expedited regulatory pathways is questionable.

Abstract

Cédric Lemarchand and colleagues highlight weaknesses in the evidence on efficacy and safety of hallucinogens and question the use of expedited regulatory pathways

Citations in the library